Landfar Bio-medicine: Announcement of abnormal fluctuations in the trading of Landfar Bio-Medicine stocks.
Landfar Bio-medicine: Nanhua Biotech Stock Trading Abnormal Fluctuation Notice
Landfar Bio-medicine: Nanhua Biotech Stock Trading Abnormal Fluctuation Notice
Landfar Bio-medicine: Nanhua Biotech's announcement on uncompensated losses exceeding one-third of the total paid-up share capital in 2023
Landfar Bio-medicine: Western Securities Co., Ltd. inspection opinions on the 2023 internal control self-evaluation report of Nanhua Biopharmaceutical Co., Ltd.
Landfar Bio-medicine: Report on the work of the board of directors of Nanhua Biotech 2024
Landfar Bio-medicine: Nanhua Biotech 2023 Supervisory Board Work Report
Landfar Bio-medicine: Western Securities Co., Ltd.'s inspection opinion on Nanhua Biopharmaceutical Co., Ltd.'s 2024 daily related transaction forecast
Landfar Bio-medicine: Special explanation on the occupation of non-operating capital and other related capital transactions in 2023
Landfar Bio-medicine: Special instructions on the use of funds raised in the year
Landfar Bio-medicine: Western Securities Co., Ltd.'s inspection opinion on Nanhua Biopharmaceutical Co., Ltd.'s use of idle funds to entrust financial management and related transactions
Landfar Bio-medicine: Nanhua Biotech's announcement on the use of idle funds for entrusted financial management and related transactions
Landfar Bio-medicine: Nanhua Biotech's 2023 Independent Director Debriefing Report (Zhao Yaqing)
Landfar Bio-medicine: Annual Verification Report on the Use of Raised Funds
Landfar Bio-medicine: Nanhua Biotech's Assessment Report on the Performance Status of Accounting Firms in 2023
Landfar Bio-medicine: Announcement of Board Resolutions
Landfar Bio-medicine: Nanhua Biotech's announcement on applying for a comprehensive credit line from a bank
Landfar Bio-medicine: Special inspection opinion of Western Securities Co., Ltd. on the storage and use of funds raised by Nanhua Biopharmaceutical Co., Ltd.
Landfar Bio-medicine: Internal Control Audit Report
Landfar Bio-medicine: Annual special audit report on the expenditure of related parties' funds
No Data